[Application of endolaser in vitrectomy for retinal vascular disease].
OBJECTIVE
To discuss the usage and effectiveness of endolaser in vitrectomy for retinal vascular disease.


METHODS
Twenty-four cases (28 eyes) of vitrectomy for retinal vascular disease were treated with endolaser. The methods of endolaser: 21 eyes were treated with panretinal scatter therapy; 2 eyes with endolaser ring-intercepting around retinal and sealing retinal breaks; 5 eye with focal therapy.


RESULTS
After follow-up for 1-24 months (mean 9 months), retinal hemorrhage recurred in 3 eyes; the other 25 eyes, retinas were totally reattached, retinal breaks were sealed, and vision had considerable recovery, no hemorrhage. The ratio of recovery is up to 89.2%.


CONCLUSIONS
Endolaser is an important adjuvant in vitreous operation nowadays and an effective procedure in vitrectomy for the cases of retinal hemorrhage.
Zang
Jing
J
Guangzhou Railway Central Hospital, Guangzhou 510080, China.
Zhou
Binbing
B
Bao
Jionglin
J
Zhu
Yudong
Y
Lin
Wenxiong
W
Li
Qing
Q
Bian
Qingning
Q
Zhang
Shaochong
S
Gao
Rulong
R
He
Lirong
L
D000293:Adolescent; D000328:Adult; D000368:Aged; D003930:Diabetic Retinopathy / Q000150:complications / Q000601:surgery*; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D017075:Laser Coagulation; D008297:Male; D008875:Middle Aged; D012164:Retinal Diseases; D014792:Visual Acuity; D014821:Vitrectomy / Q000379:methods; D018630:Vitreoretinopathy, Proliferative / Q000150:complications / Q000601:surgery; D014823:Vitreous Hemorrhage / Q000150:complications / Q000601:surgery*